Home > Income Statement > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Consolidated Net Profit

    Back to Income Statement
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Consolidated Net Profit ₹49 Cr₹25 Cr₹20 Cr₹20 Cr₹1,053,410 Cr

What is the latest Consolidated Net Profit of SYNCOM FORMULATIONS (INDIA) ?

The latest Consolidated Net Profit ratio of SYNCOM FORMULATIONS (INDIA) is ₹49 Cr based on Mar2026 Consolidated results.
Year Consolidated Net Profit
Mar2026₹49 Cr
Mar2025₹25 Cr
Mar2024₹20 Cr
Mar2023₹20 Cr
Mar2022₹1,053,410 Cr

How is Consolidated Net Profit of SYNCOM FORMULATIONS (INDIA) Trending?

Years Consolidated Net Profit % Change
Mar2026 ₹49 Cr
95.29
Mar2025 ₹25 Cr
26.12
Mar2024 ₹20 Cr
1.42
Mar2023 ₹20 Cr
-100.00
Mar2022 ₹1,053,410 Cr -

Compare Consolidated Net Profit of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,885.6 Cr 1.3% 17.8% 12.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹444,717.0 Cr -0.8% -2.5% 11.9% Stock Analytics
DIVIS LABORATORIES ₹255,115.0 Cr 1.9% 6.6% 55.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,613.0 Cr 0.3% 2% 35.9% Stock Analytics
CIPLA ₹112,876.0 Cr 0.9% -0.8% -10.9% Stock Analytics
DR REDDYS LABORATORIES ₹100,395.0 Cr 0.1% 1.4% -9.3% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

1.3%

17.8%

12.2%

SENSEX

-0.5%

-4.8%

-11%


You may also like the below Video Courses